-+ 0.00%
-+ 0.00%
-+ 0.00%

PRELUDE THERAPEUTICS ANNOUNCES ACCEPTANCE OF PRECLINICAL ABSTRACT FOR PRT13722, A FIRST-IN-CLASS ORAL KAT6A SELECTIVE DEGRADER AT THE 2026 AACR ANNUAL MEETING

Reuters·03/17/2026 20:31:00

Please log in to view news